Global Information
회사소개 | 문의 | 비교리스트

스코폴라민 시장 : 규모, 점유율, 동향, 예측(-2026년)

Scopolamine Market - Size, Share, Trends, and Forecast to 2026

리서치사 Coherent Market Insights
발행일 2018년 07월 상품 코드 785777
페이지 정보 영문
가격
US $ 4,500 ₩ 5,293,000 PPT Turned PDF (Single User License)
US $ 7,000 ₩ 8,234,000 PPT Turned PDF (Multi-user License)
US $ 10,000 ₩ 11,763,000 PPT Turned PDF (Enterprise User License)


스코폴라민 시장 : 규모, 점유율, 동향, 예측(-2026년) Scopolamine Market - Size, Share, Trends, and Forecast to 2026
발행일 : 2018년 07월 페이지 정보 : 영문

스코폴라민은 항콜린작용, 제토작용, 항천식작용을 하는 의약품이며, 경구약, 주사제, 점안액, 국소 약물로서 입수 가능합니다.

세계의 스코폴라민(Scopolamine) 시장을 조사했으며, 시장 개요, 제형·유통경로·지역별 시장 규모 추이와 예측, 시장 성장 촉진요인 및 저해요인 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 제공합니다.

목차

제1장 조사 목적과 전제조건

  • 조사 목적
  • 전제조건
  • 약어

제2장 시장 개요

  • 보고서 설명
    • 시장 정의와 범위
  • 주요 요약
    • 시장 개요 : 제형별
    • 시장 개요 : 유통경로별
    • 시장 개요 : 지역별
  • Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

  • 시장 역학
    • 성장 촉진요인
    • 성장 저해요인
    • 시장 기회
  • 영향 분석
  • 시장 동향
  • 주요 개발 동향
  • 역학
  • 연혁
  • 의약품의 수익 가능성
  • Five Forces 분석
  • PEST 분석

제4장 세계의 스코폴라민 시장 : 제형별

  • 서론
  • 알약
  • 시럽
  • 주사제
  • 패치
  • 기타

제5장 세계의 스코폴라민 시장 : 유통채널별

  • 서론
  • 병원 약국
  • 소매 약국
  • 온라인 약국

제6장 세계의 스코폴라민 시장 : 지역별

  • 서론
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 아프리카
  • 중동

제7장 경쟁 환경

  • 히트 맵 해석
  • 기업 개요
    • Baxter International Inc.
    • GlaxoSmithKline plc
    • Novartis AG
    • Perrigo Company plc.
    • Caleb Pharmaceuticals, Inc.
    • Myungmoon Pharma Co. LTD.
    • Alchem International
    • Phytex Australia
    • Centroflora-Cms
    • Alkaloids of Australia
    • Fine Chemicals Corporation
  • 애널리스트의 견해

제8장 섹션

  • 참고 문헌
  • 조사 방법
  • Coherent Market Insights에 대해
LSH 19.03.04

Scopolamine is an oral, intravenous, ophthalmic or topical drug derived from plants of the nightshade family (Solanaceae), specifically Hyoscyamus Niger and Atropa belladonna, with anticholinergic, antiemetic and antivertigo properties.

It has applications in prevention of nausea, vomiting, and dizziness associated with motion sickness and recovery from anesthesia and surgery. Scopolamine may also be used to treat certain stomach or intestinal problems, such as spastic muscle states, diverticulitis, irritable bowel syndrome, Parkinson-like conditions etc.

Market Dynamics

Changing lifestyle that involves minimal or absolutely no physical work in a routine life are responsible for the malfunctioning of the digestive as well as gastrointestinal system. Increasing number of population adopting long-hour sedentary work lifestyle are likely to be affected with gastrointestinal disorders such as irritable bowel syndrome and thus are responsible to support growth of the global scopolamine market.

However, various side-effects observed while using these drugs such as retarded motion, drowsiness, and diluted pupils, may limit their growth to some extent in the near future.

Key features of the study:

This report provides in-depth analysis of the scopolamine market, market size (US$ Mn) and cumulative annual growth rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017 as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by the leading players

It profiles leading players in the global scopolamine market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies

Key players covered as a part of this study include Baxter International Inc., GlaxoSmithKline plc, Novartis AG, Perrigo Company plc, Caleb Pharmaceuticals, Inc., Myungmoon Pharma Co. LTD., Alchem International, Phytex Australia, Centroflora-Cms, Alkaloids of Australia, and Fine Chemicals Corporation.

Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics

The global scopolamine market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for scopolamine market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Scopolamine Market, By Dosage Form:
  • Tablet
  • Syrup
  • Injection
  • Patch
  • Others
  • Global Scopolamine Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Global Scopolamine Market, By Region:
  • North America
  • By Country:
  • U.S.
  • Canada
  • By Dosage Form:
  • Tablet
  • Syrup
  • Injection
  • Patch
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Europe
  • By Country:
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
  • By Dosage Form:
  • Tablet
  • Syrup
  • Injection
  • Patch
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Asia Pacific
  • By Country:
  • Australia
  • India
  • China
  • Japan
  • ASEAN
  • South Korea
  • Rest of Asia Pacific
  • By Dosage Form:
  • Tablet
  • Syrup
  • Injection
  • Patch
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Latin America
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • By Dosage Form:
  • Tablet
  • Syrup
  • Injection
  • Patch
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Middle East
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • By Dosage Form:
  • Tablet
  • Syrup
  • Injection
  • Patch
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Africa
  • By Country:
  • South Africa
  • Central Africa
  • North Africa
  • By Dosage Form:
  • Tablet
  • Syrup
  • Injection
  • Patch
  • Others
  • By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Company Profiles
  • Baxter International Inc.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • GlaxoSmithKline plc
  • Novartis AG
  • Perrigo Company plc.
  • Caleb Pharmaceuticals, Inc.
  • Myungmoon Pharma Co. LTD.
  • Alchem International
  • Phytex Australia
  • Centroflora-Cms
  • Alkaloids of Australia
  • Fine Chemicals Corporation
  • “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Dosage Form
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Epidemiology
  • Historical Overview
  • Revenue Potential of Drugs
  • PORTER'S Five Forces
  • PEST Analysis

4. Global Scopolamine Market, By Dosage Form, 2016 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Tablet
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Syrup
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Injection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Patch
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

5. Global Scopolamine Market, By Distribution Channel, 2016 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

6. Global Scopolamine Market, By Regions, 2016 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, By Region, 2016 - 2026
    • Regional Trends
  • North America
    • Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • Northern Africa
    • Central Africa
    • South Africa
  • Middle East
    • Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • GCC Countries
    • Israel
    • Rest of Middle East

7. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Baxter International Inc.
    • Company Overview
    • Dosage Form Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • GlaxoSmithKline plc
    • Company Overview
    • Dosage Form Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Novartis AG
    • Company Overview
    • Dosage Form Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Perrigo Company plc.
    • Company Overview
    • Dosage Form Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Caleb Pharmaceuticals, Inc.
    • Company Overview
    • Dosage Form Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Myungmoon Pharma Co. LTD.
    • Company Overview
    • Dosage Form Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Alchem International
    • Company Overview
    • Dosage Form Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Phytex Australia
    • Company Overview
    • Dosage Form Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Centroflora-Cms
    • Company Overview
    • Dosage Form Portfolio
    • Financial Performance
    • Recent Highlights
    • Alkaloids of Australia
    • Company Overview
    • Dosage Form Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Fine Chemicals Corporation
    • Company Overview
    • Dosage Form Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Analyst Views

8. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Back to Top
전화 문의
F A Q